ZKIN
ZK International Group Co., Ltd.
There isn't enough reported data to score ZKIN yet.
ZKIN Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Unavailable | |
| Unavailable | |
| Unavailable |
There isn't enough reported data to rate ZKIN's fundamentals.
ZKIN PE Valuation
ZKIN has no meaningful PE right now: it lost money over the past year.
ZKIN Forward outlook
There aren't enough analyst estimates for ZKIN to show an outlook.
ZKIN Earnings Per Share
ZKIN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q1 2026 | $1M | -97% |
| Q3 2025 | $31.2M | -44% |
| Q1 2025 | $40M | -24% |
| Q3 2024 | $55.3M | -11% |
| Q1 2024 | $52.9M | +6.5% |
| Q3 2023 | $61.9M | +4.1% |
| Q1 2023 | $49.7M | +16% |
| Q3 2022 | $59.5M | +4% |
ZKIN's revenue has slid since its 2023 peak: $1M last quarter, down 98% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q1 2026 | -797% | -797 points |
| Q3 2025 | -6.4% | +91 points |
| Q1 2025 | -1.2% | -1.5 points |
| Q3 2024 | -3.4% | +3.7 points |
| Q1 2024 | 0.3% | -0.3 points |
| Q3 2023 | -98% | -94 points |
| Q1 2023 | 0.3% | +4.2 points |
| Q3 2022 | -7.1% | -2.3 points |
ZKIN's operating margin was −797% last quarter, down 797 points from the same quarter a year ago, near the bottom of its range since 2017.
ZKIN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q1 2026 | -$18.1M | -$18.1M |
| Q3 2025 | $191.8K | +$191.8K |
| Q1 2025 | $0 | $0 |
| Q3 2024 | $0 | $0 |
| Q1 2024 | $0 | $0 |
| Q3 2023 | $0 | -100% |
| Q1 2023 | $0 | +$6M |
| Q3 2022 | $2.7M | +275% |
ZKIN's free cash flow has turned negative after years in the green: −$18M over the past year.
ZKIN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +230% | +13.3M shares |
| 1 year | +326% | +14.6M shares |
| 3 years | +709% | +16.8M shares |
ZKIN has 19M diluted shares, up 326% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2026 | — |
| Q3 2025 | — |
| Q1 2025 | — |
| Q3 2024 | — |
| Q1 2024 | — |
| Q3 2023 | — |
| Q1 2023 | — |
| Q3 2022 | — |
ZKIN Net Leverage
ZKIN's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
ZKIN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.3 | Neutral |
| Stochastic | 31.9 | Neutral |
ZKIN's weekly RSI is 51 (neutral) and its Stochastic is 32 (neutral).
ZKIN PE vs Basic Materials Sector
ZKIN has no meaningful PE right now: it lost money over the past year.
ZKIN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.68 | 7.7% below |
| 20 week MA | $1.40 | 11% above |
| 50 week MA | $1.51 | 2.6% above |
| 100 week MA | $1.95 | 21% below |
| 200 week MA | $3.29 | 53% below |
ZKIN's trend is mixed: it's above two of its five weekly moving averages, and 53% below its 200-week average.
ZKIN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2022 | $8.02 | $3.54 | -56% |
| 2023 | $3.54 | $6.86 | +94% |
| 2024 | $6.86 | $4.89 | -29% |
| 2025 | $4.89 | $1.65 | -66% |
| 2026 YTD | $1.65 | $1.55 | -6.1% |
ZKIN has finished lower in three of the last four years. It's down 6.1% so far in 2026.